Skip to main content
OpenTrials

Clinical trial condition

Papillomavirus Infections

Explore clinical trials studying Papillomavirus Infections. Study availability and eligibility vary by location and protocol.

52 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Papillomavirus Infections trial results

Not yet recruiting

Hexaminolevulinate Photodynamic Therapy (HAL-PDT) With Deferred Surgery Versus Surgery for High-grade Squamous Intraepithelial Lesions (HSIL)

NCT07669363

Conditions
Cervical Intraepithelial Neoplasia, Communicable Diseases, DNA Virus Infections, +21 more
Locations
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China
  • Xiamen Maternity and Child Healthcare Hospital Xiamen, Fujian, China
  • he First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
View all 28 locations
View Trial Details
Active, not recruiting

Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023)

NCT03998254

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +10 more
Locations
  • Lingchuan Center for Disease Control and Prevention ( Site 0002) Guilin, Guangxi, China
  • Quanzhou Center for Disease Control and Prevention ( Site 0001) Guilin, Guangxi, China
  • Xiangyuan Center for Disease Control and Prevention ( Site 0003) Changzhi, Shanxi, China
  • Yanhu Center for Disease Control and Prevention of Yuncheng ( Site 0004) Yuncheng, Shanxi, China
View Trial Details
Active, not recruiting

Safety and Immunogenicity of Extended 2-dose Regimens of 9-valent Human Papillomavirus (9vHPV) Vaccine (V503-069)

NCT04708041

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +10 more
Locations
  • Kaiser Permanente Daly City ( Site 0044) Daly City, California, United States
  • Kaiser Permanente Oakland ( Site 0020) Oakland, California, United States
  • Kaiser Permanente Roseville ( Site 0047) Roseville, California, United States
  • Kaiser Permanente Sacramento ( Site 0043) Sacramento, California, United States
View all 30 locations
View Trial Details
Active, not recruiting

Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)

NCT04199689

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +10 more
Locations
  • Valley Clinical Trials Inc. ( Site 0002) Northridge, California, United States
  • Inland Empire Clinical Trials, LLC ( Site 0025) Rialto, California, United States
  • Alta California Medical Group ( Site 0031) Simi Valley, California, United States
  • Encompass Clinical Research ( Site 0028) Spring Valley, California, United States
View all 103 locations
View Trial Details
Active, not recruiting

Efficacy, Immunogenicity, and Safety of V503 in Chinese Males (V503-052)

NCT05285826

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +10 more
Locations
  • Beijing Youan Hospital ( Site 0001) Beijing, Beijing Municipality, China
  • The Second Affiliated Hospital Chongqing Medical University ( Site 0052) Chongqing, Chongqing Municipality, China
  • Chongqing Public Health Medical Center ( Site 0003) Chongqing, Chongqing Municipality, China
  • The First Hospital of Lanzhou University ( Site 0034) Lanzhou, Gansu, China
View all 34 locations
View Trial Details

Related conditions